Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÈòÁã Çظ¶¿¡¼­ Acetylcholine À¯¸®¿¡ ¹ÌÄ¡´Â Protein Kinase CÀÇ ¿ªÇÒ¿¡ °üÇÑ ¿¬±¸ A Study on the Role of Protein Kinase C upon the Acetylcholine Release in the Rat Hippocampus

´ëÇѽŰæ¿Ü°úÇÐȸÁö 1995³â 24±Ç 2È£ p.115 ~ 122
±èÁ¾¼º, °­¼ºµ·, ÀåžÈ, ÃÖÁ¤ÈÆ,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁ¾¼º (  ) 
¿ø±¤´ëÇб³

°­¼ºµ· (  ) 
¿ø±¤´ëÇб³
ÀåžȠ(  ) 
¿ø±¤´ëÇб³
ÃÖÁ¤ÈÆ (  ) 
¿ø±¤´ëÇб³

Abstract


The effects and interactions of 4¥â-phorbol 12. 13-dibutyrate (PDB) and polymyxin B (PMB) with adenosine on the electrically-evoked acetylcholine (ACh) release were studied in rate hippocampus. Slices from rat hippocampus were equilibrated with
3H-choline and the release of the labelled product. 3H-ACh. which was evoked by electrical stimulation (3Hz. 2ms. 5VCm1. rectangular pulses) was measured.
PDB (0.3-10¥ìM). a selective protein kinase C (PKC) activator. increased the evoked ACh release in a dose related fashion with an increase in the basal rate of release. The effects of 1¥ìM PDB were significantly inhibited by 0.3¥ìM tetrodotoxin
(TTX)
pretreatment or Ca++-free medium. PMB (0.03-1mg). a selective PKC inhibitor. decreased the ACh release in a dose dependent manner with an increase in the basal rate of release.
Adenosine (1-01¥ìM) decreased the ACh release without changing the basal rate of release. and this effect was significantly inhibited by 8-cyclopentyl-1.3-dipropylxanthine (2¥ìM). a selective A1-receptor antagonist treatment. However. adenosine
effects
were not affected by PDB and PMB.
These results indicate that the PKC play a role in the ACh release in the rat hippocampus but is not involved in the post-receptor mechanism of the A1-adenosine receptor.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS